European Maritime Day

Zoan BioMed was the first company to be introduced at the conference – ‘Bringing Blue Innovation to the Market’. We presented our business and detailed our commercialisation plans after FDA approval. Of particular interest was the sustainability credentials of the Zoan BioMed platform – the first company in its industry to commit towards a short term goal of being carbon neutral in its production facility. Thank you to moderator Vincent Favrel and all our friends at the European Climate, Infrastructure and Environment Executive Agency.

Latest News

Northwell Health USA and Portershed Galway Visit Zoan

We were delighted to have the opportunity to host, Mary Rodgers (CEO, PorterShed Galway) ,
Kevin Beiner (Senior Vice President and Regional Executive Director, Northwell Health) Elaine
Brennan (Executive Director & Chief Commercialization Officer at Northwell Health) Jennifer
Scanlon (AVP Strategic Partnerships at Northwell Health) to our facility last week.

KPMG Global Tech Innovator Finalist

Dublin, June 2022 Zoan Biomed was chosen as one of the finalists in the KPMG Global Tech Innovator series. With 70+ impressive entrants representing the very best innovations in Ireland, the 8 finalists got to present to some of Ireland’s leading business personalities.
The Zoan Biomed innovation was lauded for its uniqueness, impact to industry and sustainability credentials.

Zoan BioMed & CELLINK Sign Co-Development Partnership

Dublin, Boston, Gothenburg – April, 2022—Imagine a future where a bone break can be repaired by 3D-printing bones made from marine coral. That reality may come a lot sooner that one might think, thanks to a truly innovative collaboration agreement between Irish-owned, and Galway-based, Zoan BioMed, and Sweden-based CELLINK (STO: BICO). Uniquely, Zoan BioMed sustainably grows…

Zoan Biomed Partnership with the European Maritime Fisheries Fund

In 2019 we launched our partnership with the European Maritime and Fisheries Fund of the European Union, CORAL4HEALTH. A 2-year engagement that initiated with high expectations and acknowledgment of the considerable innovation challenges that lay ahead. The overall aim of the CORAL4HEALTH project was to commercialise the next generation graft bone substitutes, drawn from a…

Contact Us

To find out more about Zoan BioMed get in touch